elinda
i think there is no problem with asking your consultant what evidence he basing his decision on. blood tests are no good really as they are only a snapshot in time and one solitary blood test should never be used as evidence… this is even if you werent on tamoxifen or any other hormonal treatment.
i was told in january i was going through the menopause following chemo my gp disputed this and wanted to do blood tests, however from my background in family planning i felt this was a bit of a waste of space seeing i was on tamoxifen and have a mirena coil in… but went along with it…
my menopausal bloods were raised indicating i was post menopausal but my oestrogen was still a bit high indicating that there was still some ovarian function so the blood tests were repeated and the showed that the menopausal bloods were still high but ovarian function was back to normal so basically i am going through the menopause!!!
i have been on tamoxifen for 3 1/2 years so have a year and half left but will be getting my ovaries out sometime this year as im a brca 2 gene carrier.
there has been no mention of changing to an AI and im quite happy to just stick with tamoxifen… it has been one of the wonder drugs of the last century and saved thousands of women’s lives.
i have been doing a bit of researching and found some research papers which indicate that AIs can stimulate ovarian function in women thought to be menopausal
this is a quote from the paper…
“The treatment of premenopausal or perimenopausal women with aromatase inhibitors can have serious consequences. These can include pain from ovarian hyperstimulation induced by aromatase inhibitors,12 13 14 as well as the increased risk of unplanned pregnancy.15 Aromatase inhibitors can also trigger a reflex increase in gonadotrophins, which causes an increase in ovarian production of aromatase and oestrogens, and can lead to an increased risk of breast cancer recurrence.”
Amenorrhoea, menopause, and endocrine therapy for breast cancer
written by Eitan Amir, medical oncology fellow, Bostjan Seruga, medical oncology fellow, Orit Freedman, medical oncology fellow, Mark Clemons, medical oncologist and published in the BMJ in December last year so its up to date evidence.
this is the one that mentions increased ovarian function
“A total of 45 such women were identified in the audit, with a median age of 47 years (range, 39 to 52 years). Twelve women (27%) showed a return of ovarian function (10 renewed menses, one pregnancy, one biochemically premenopausal) after starting an AI. Median age at restart of ovarian function was 44 years (range, 40 to 50 years).”
Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines
written by Ian E. Smith, Mitch Dowsett, Yoon-Sim Yap, Geraldine Walsh, Per E. Lønning, Richard J. Santen, Daniel Hayes
was published in the American Journal of oncology in 2006 Ian Smith is consultant at the Marsden.
i would say from the reading of these research papers that taking an AI at present would be unsafe. however were you to have your ovaries out which you mentioned earlier it would probably be effective as there would be no risk of you becoming premenstrual.
sorry its so long but hope it helps
i have an athens password so can access the full text of the 2009 article but not sure if you can read without this… but can probably copy extracts and reference lists if you wanted to show your consultant.
Lulu x